A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults

NCT05627258 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

NIH

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: VRC-HIVMAB0115-00-AB

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)